These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

156 related articles for article (PubMed ID: 4696261)

  • 1. [Production and control in the pharmaceutical industry. Treatment of initial substances and materials. Organization and practice in larger plants].
    Büchler W
    Pharm Acta Helv; 1973 Jan; 48(1):11-21. PubMed ID: 4696261
    [No Abstract]   [Full Text] [Related]  

  • 2. [Production and control in the pharmaceutical industry. Treatment of initial substances and materials. Organization and practice in medium-size plants].
    Schlumpf R
    Pharm Acta Helv; 1973 Jan; 48(1):22-36. PubMed ID: 4696263
    [No Abstract]   [Full Text] [Related]  

  • 3. [Production and control in the pharmaceutical industry. Treatment of initial substances and materials. Requirements of the iks (intercantonal control agency) guide lines].
    Zinn W
    Pharm Acta Helv; 1973 Jan; 48(1):1-21. PubMed ID: 4696262
    [No Abstract]   [Full Text] [Related]  

  • 4. [Production and control in pharmaceutical industry. Testing of samples and release. Organization and practice in middle-sized plants].
    Schlumpf R
    Pharm Acta Helv; 1973; 48(8):471-81. PubMed ID: 4766788
    [No Abstract]   [Full Text] [Related]  

  • 5. [Production and control in pharmaceutical industry. Testing of samples and release. Organization and practice in bigger plants].
    Forster O
    Pharm Acta Helv; 1973; 48(8):455-70. PubMed ID: 4766787
    [No Abstract]   [Full Text] [Related]  

  • 6. [Practical realization of manufacturing control in Switzerland].
    Witschi T
    Pharm Acta Helv; 1972; 47(11):637-47. PubMed ID: 4657533
    [No Abstract]   [Full Text] [Related]  

  • 7. [Production and control in pharmaceutic industry. Claims and principles in production of sterile preparations. Claims of IKS principles].
    Witschi T
    Pharm Acta Helv; 1973 Feb; 48(2):53-62. PubMed ID: 4706309
    [No Abstract]   [Full Text] [Related]  

  • 8. [Production and control in the pharmaceutical industry. Labeling, packaging and control of endproducts. Organization and practice in smaller plants].
    Baeschlin K
    Pharm Acta Helv; 1973; 48(6):358-70. PubMed ID: 4729557
    [No Abstract]   [Full Text] [Related]  

  • 9. [Production and control in the pharmaceutical industry. Labeling, packaging and control of endproducts. Organization and practice in large plants].
    Hinsen W
    Pharm Acta Helv; 1973; 48(6):322-38. PubMed ID: 4729555
    [No Abstract]   [Full Text] [Related]  

  • 10. [Manufacturing and control in pharmaceutical industry. Introduction into manufacturing control. Introduction].
    Hippenmeier F
    Pharm Acta Helv; 1972; 47(11):625-8. PubMed ID: 4657531
    [No Abstract]   [Full Text] [Related]  

  • 11. [Elaboration of examination rules for initial substances and end products].
    Hubmann E
    Pharm Acta Helv; 1973; 48(8):443-54. PubMed ID: 4766786
    [No Abstract]   [Full Text] [Related]  

  • 12. [Production and control in pharmaceutic industry. Claims and principles in production of sterile preparations. Production in bigger plants].
    Schnorf U
    Pharm Acta Helv; 1973 Feb; 48(2):83-100. PubMed ID: 4706311
    [No Abstract]   [Full Text] [Related]  

  • 13. [Production and control in the pharmaceutical industry. Labeling, packaging and control of endproducts. Organization and practice in medium-size plants].
    Schmid HW
    Pharm Acta Helv; 1973; 48(6):339-57. PubMed ID: 4729556
    [No Abstract]   [Full Text] [Related]  

  • 14. [Maintaining standards of good compounding (N.B.F.)].
    Castoldi B; Fumagalli A; Mazzoldi G
    Boll Chim Farm; 1978 Dec; 117(12):689-99. PubMed ID: 752351
    [No Abstract]   [Full Text] [Related]  

  • 15. Report on the PQRI impurity characterization and quantification best practices survey.
    Faustino P; Chan CC; Carrano J; Gosnell M; Gu ZQ; Maule A; Sigvardson K; Zhang YF
    Pharm Res; 2006 Feb; 23(2):440-6. PubMed ID: 16477396
    [No Abstract]   [Full Text] [Related]  

  • 16. [Round table on the "norms for good drug compounding"].
    Boll Chim Farm; 1970 Nov; 109(11):635-52. PubMed ID: 5515584
    [No Abstract]   [Full Text] [Related]  

  • 17. International Conference on Harmonisation; guidance on good manufacturing practice for active pharmaceutical ingredients; availability. Notice.
    Food and Drug Administration, HHS
    Fed Regist; 2001 Sep; 66(186):49028-9. PubMed ID: 12358036
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Drug product quality.
    Exp Med Surg; 1971; 29(1):135-44. PubMed ID: 5147595
    [No Abstract]   [Full Text] [Related]  

  • 19. Draft guidelines on compounding of nonsterile products in pharmacies. American Society of Hospital Pharmacists.
    Am J Hosp Pharm; 1993 Jul; 50(7):1452-61. PubMed ID: 8362883
    [No Abstract]   [Full Text] [Related]  

  • 20. [Quality control in the pharmaceutical industry].
    Sloot HA
    Pharm Weekbl; 1968 Apr; 103(17):506-16. PubMed ID: 5665061
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.